Possible mechanisms of immunotoxicity following in vivo exposure to the inhalant, isobutyl nitrite.
Soderberg
L S
LS
Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock 72205, USA.
Barnett
J B
JB
D000280:Administration, Inhalation; D000818:Animals; D004912:Erythrocytes / Q000276:immunology; D005260:Female; D007111:Immunity, Cellular / Q000187:drug effects*; D007375:Interleukin-1 / Q000096:biosynthesis; D051379:Mice; D008810:Mice, Inbred C57BL; D009569:Nitric Oxide / Q000378:metabolism; D009573:Nitrites / Q000008:administration & dosage / Q000633:toxicity*; D012756:Sheep / Q000276:immunology; D013154:Spleen / Q000166:cytology / Q000187:drug effects; D019966:Substance-Related Disorders / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000633:toxicity*
D007375:Interleukin-1; D009573:Nitrites; D014409:Tumor Necrosis Factor-alpha; D014665:Vasodilator Agents; D009569:Nitric Oxide; C018086:isobutyl nitrite